857762-32-4 Usage
Uses
Used in Pharmaceutical Industry:
6-BROMO-3-CHLORO-4-HYDROXYQUINOLINE is used as a chemical intermediate for the synthesis of various drugs and pharmaceuticals. Its unique structure makes it a valuable building block in the development of new medicinal products.
Used in Antimicrobial Applications:
6-BROMO-3-CHLORO-4-HYDROXYQUINOLINE is used as a potential antimicrobial agent, being studied for its ability to combat various microorganisms. Its effectiveness in this area could contribute to the development of new treatments for infectious diseases.
Used in Antiviral Applications:
6-BROMO-3-CHLORO-4-HYDROXYQUINOLINE is used as a potential antiviral agent, with research being conducted to explore its ability to inhibit viral replication and infectivity. This could lead to the creation of new antiviral medications.
Used in Environmental and Biological Research:
6-BROMO-3-CHLORO-4-HYDROXYQUINOLINE is used as a fluorescent probe for detecting metal ions in biological and environmental samples. Its fluorescent properties allow for the sensitive and selective detection of metal ions, which is important for various analytical and diagnostic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 857762-32-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,7,7,6 and 2 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 857762-32:
(8*8)+(7*5)+(6*7)+(5*7)+(4*6)+(3*2)+(2*3)+(1*2)=214
214 % 10 = 4
So 857762-32-4 is a valid CAS Registry Number.
InChI:InChI=1/C9H5BrClNO/c10-5-1-2-8-6(3-5)9(13)7(11)4-12-8/h1-4H,(H,12,13)
857762-32-4Relevant academic research and scientific papers
CRYSTALLINE FORMS OF SOMATOSTATIN MODULATORS
-
Paragraph 00235, (2021/02/12)
Described herein are pharmaceutically acceptable salts of a somatostatin modulator, crystalline forms of the pharmaceutically acceptable salts of the somatostatin modulator, methods of making such salts and crystalline forms, pharmaceutical compositions and medicaments comprising such salts and crystalline forms, and methods of using such salts and crystalline forms in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
PROCESS OF MAKING SOMATOSTATIN MODULATORS
-
Paragraph 0392, (2019/07/29)
Described herein are compounds that are somatostatin modulators, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of somatostatin activity.
